AI Drug Discovery & Neurotech Lead Week's Deals | StartUp Health Insights: Week of Mar 18, 2025
This week’s global health innovation funding highlights include a $110M round for AI-driven drug discovery, major investments in genetic medicine, and digital health startups securing millions to advance chronic disease management, mental health, and neuroscience solutions.
Written by Nicole Kinsey
This week’s reported global health innovation funding included:
Insilico Medicine, a Cambridge, MA-based clinical-stage generative AI-driven drug discovery company, raised $110M led by Value Partners Group, with participation from new and existing investors. <source>
Arbor Biotechnologies, a Cambridge, MA-based biotech company discovering and developing genetic medicines, raised $73.9M led by ARCH Venture Partners and TCGX, with participation from QIA, Partners Investment, Revelation Partners, Kerna Ventures, Ally Bridge Group, Arrowmark Partners, Deep Track Capital, Piper Heartland Healthcare Capital, Surveyor Capital, Temasek, T. Rowe Price Associates, Vertex Pharmaceuticals Incorporated, and funds managed by abrdn Inc. <source>
MicroTransponder, an Austin, TX-based medical device company focused on developing research-based neuroscience solutions, raised $65M led by US Venture Partners (USVP), with participation from Osage University Partners, Action Potential Venture Capital, GPG Ventures, The Vertical Group, Exceller Hunt Ventures, Gilde Healthcare, and Longitude Capital. <source>
Vori Health, a Nashville, TN-based hybrid musculoskeletal care provider, raised $53M led by NEA, with participation from Echo Health Ventures, Max Ventures, AlleyCorp, and Intermountain Ventures. <source>
Phoenix, a Toronto, ON, Canada-based digital health clinic for men, raised CAD $50M (US$35M) led by Valspring Capital, with participation from Y Combinator and CIBC Innovation Banking. <source>
Motivity, a Seattle, WA-based clinical SaaS platform for applied behavior analysis (ABA) providers who treat children with autism, raised $27M from Five Elms Capital. <source>
Perfuze, a Galway, Ireland-based medical device company focused on enhancing stroke treatment capabilities, raised €22M ($24M) led by Earlybird, EQT Life Sciences, Seroba, and SV Health. <source>
Health2Sync, a Taipei City, Taiwan-based digital chronic disease management platform, raised $20M led by Taiwania Capital, with participation from Wistron, Pegatron, BE Health Ventures, ABIES Capital, and Cathay Venture. <source>
Strolll, a Stafford, UK-based digital therapeutic software company focused on improving the conditions of people living with neurological disorders such as Parkinson’s disease, stroke, and MS, raised £10.35M ($13.45M) led by IW Capital. <source>
Vantis, a Munich, Germany-based digital care innovation company for chronic disease management, raised €10M ($10.9M) led by Angelini Ventures, with participation from Bayern Kapital, Twip Impact Ventures, firstminute, and b2venture. <source>
AdvocateMH, a Boston, MA-based mental health platform that connects people to condition-appropriate care, raised $6.2M led by Morningside. <source>
elea, a Hamburg, Germany-based company providing an immersive AI platform for healthcare professionals that provide life-saving diagnoses and care, raised €4M ($4.4M) from Fly Ventures, Giant Ventures, and MVZ (Medizinische Versorgungszentrum) hospital groups. <source>
flowww, a Valencia, Spain-based platform for optimising the daily operations of aesthetic medicine, healthcare, and beauty businesses, raised €4M ($4.4M) led by Swanlaab Venture Factory and Bonsai Partners, with participation from Sabadell Venture Capital. <source>
Vibrant, a San Francisco, CA-based practice platform for functional and longevity medicine, raised $1.7M from Anthemis Group, Emerson Collective, Lombardstreet Ventures, Dria Ventures, and Hustle Fund. <source>
Bioniq, a London, UK-based nutritional supplements company based on blood biomarker data, raised over €1M ($1.1M) from Diogo Dalot. <source>
RetinaLogik, a Calgary, AB, Canada-based VR-AI-powered platform for eye care, raised $1.1M from undisclosed funders. <source>
Porter, a Baltimore, MD-based platform for care-at-home services, raised an undisclosed amount from Eir Partners. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Innovation
Are You Ready to Find Your Tribe?
We’re looking for founders and CEOs leading digital health, life science, or biotech companies that are solving the biggest health challenges of our time – and want to build a better network to change the world. Our communities include: Alzheimer’s Disease, Cardiometabolic Health, Food as Medicine, Mental & Behavorial Health, Type 1 Diabetes, and more.
If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Follow us on social media for daily updates on Health Transformers: LinkedIn, Facebook, and Instagram.
